Department of Experimental Physiology, Medical School, National and Kapodistrian University of Athens, 75 Micras Asias str., Goudi-Athens 115 27, Greece.
Cancer Treat Rev. 2011 Jun;37(4):284-90. doi: 10.1016/j.ctrv.2010.10.002. Epub 2010 Nov 23.
Disease dissemination is the major cause of melanoma-related death. A crucial step in the metastatic process is the intravascular invasion and circulation of melanoma cells in the bloodstream with subsequent development of distant micrometastases that is initially clinically undetectable and will eventually progress into clinically apparent metastasis. Therefore, the use of molecular methods to detect circulating melanoma cells may be of value in risk stratification and clinical management of such patients. Herein, we review the currently applied techniques for the detection, isolation, enrichment and further characterization of circulating melanoma cells from peripheral blood samples in melanoma patients. Furthermore, we provide a brief overview of the various molecular markers currently being evaluated as prognostic indicators of melanoma progression.
疾病传播是导致黑色素瘤相关死亡的主要原因。在转移过程中,一个关键步骤是黑色素瘤细胞在血液中侵入血管并循环,随后发展为最初临床上无法检测到的远处微转移,并最终进展为临床上明显的转移。因此,使用分子方法检测循环中的黑色素瘤细胞可能对这些患者的风险分层和临床管理具有重要价值。在此,我们综述了目前应用于从黑色素瘤患者外周血样本中检测、分离、富集和进一步鉴定循环黑色素瘤细胞的技术。此外,我们还简要概述了目前作为黑色素瘤进展预后指标评估的各种分子标志物。